175 related articles for article (PubMed ID: 33805564)
1. The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.
Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805564
[TBL] [Abstract][Full Text] [Related]
2. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.
Ben-Shmuel A; Shvab A; Gavert N; Brabletz T; Ben-Ze'ev A
Oncogene; 2013 Jul; 32(27):3220-30. PubMed ID: 22869145
[TBL] [Abstract][Full Text] [Related]
3. A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression.
Saha A; Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008869
[TBL] [Abstract][Full Text] [Related]
4. Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.
Shvab A; Haase G; Ben-Shmuel A; Gavert N; Brabletz T; Dedhar S; Ben-Ze'ev A
Oncogene; 2016 Feb; 35(5):549-57. PubMed ID: 25915847
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.
Gavert N; Ben-Shmuel A; Lemmon V; Brabletz T; Ben-Ze'ev A
J Cell Sci; 2010 Jun; 123(Pt 12):2135-43. PubMed ID: 20501702
[TBL] [Abstract][Full Text] [Related]
6. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
[TBL] [Abstract][Full Text] [Related]
7. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
8. A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
Haase G; Gavert N; Brabletz T; Ben-Ze'ev A
Oncogene; 2017 Mar; 36(11):1597-1606. PubMed ID: 27641335
[TBL] [Abstract][Full Text] [Related]
9. Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.
Shapiro B; Tocci P; Haase G; Gavert N; Ben-Ze'ev A
Oncotarget; 2015 Oct; 6(33):34389-401. PubMed ID: 26399194
[TBL] [Abstract][Full Text] [Related]
10. A Feedback Loop between Hypoxia and Matrix Stress Relaxation Increases Oxygen-Axis Migration and Metastasis in Sarcoma.
Lewis DM; Pruitt H; Jain N; Ciccaglione M; McCaffery JM; Xia Z; Weber K; Eisinger-Mathason TSK; Gerecht S
Cancer Res; 2019 Apr; 79(8):1981-1995. PubMed ID: 30777851
[TBL] [Abstract][Full Text] [Related]
11. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
12. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.
Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y
Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425
[TBL] [Abstract][Full Text] [Related]
13. PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway.
Lan J; Zhang S; Zheng L; Long X; Chen J; Liu X; Zhou M; Zhou J
Cancer Sci; 2023 Aug; 114(8):3190-3202. PubMed ID: 37227305
[TBL] [Abstract][Full Text] [Related]
14. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
15. Procollagen Lysyl Hydroxylase 2 Expression Is Regulated by an Alternative Downstream Transforming Growth Factor β-1 Activation Mechanism.
Gjaltema RAF; de Rond S; Rots MG; Bank RA
J Biol Chem; 2015 Nov; 290(47):28465-28476. PubMed ID: 26432637
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of cathepsin D is required for L1-mediated colon cancer progression.
Basu S; Cheriyamundath S; Gavert N; Brabletz T; Haase G; Ben-Ze'ev A
Oncotarget; 2019 Aug; 10(50):5217-5228. PubMed ID: 31497251
[TBL] [Abstract][Full Text] [Related]
17. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
Gavert N; Conacci-Sorrell M; Gast D; Schneider A; Altevogt P; Brabletz T; Ben-Ze'ev A
J Cell Biol; 2005 Feb; 168(4):633-42. PubMed ID: 15716380
[TBL] [Abstract][Full Text] [Related]
18. PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.
Sheng X; Li Y; Li Y; Liu W; Lu Z; Zhan J; Xu M; Chen L; Luo X; Cai G; Zhang S
BMC Cancer; 2019 Aug; 19(1):840. PubMed ID: 31455288
[TBL] [Abstract][Full Text] [Related]
19. A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1.
Rosell-García T; Palomo-Álvarez O; Rodríguez-Pascual F
J Biol Chem; 2019 Sep; 294(39):14308-14318. PubMed ID: 31391253
[TBL] [Abstract][Full Text] [Related]
20. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling.
Wei X; Li S; He J; Du H; Liu Y; Yu W; Hu H; Han L; Wang C; Li H; Shi X; Zhan M; Lu L; Yuan S; Sun L
Cell Commun Signal; 2019 Jun; 17(1):58. PubMed ID: 31170987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
